FDA, Company Square Off in Hearing Over Drug Makena, Meant to Prevent Preterm Births

MONDAY, Oct. 17, 2022 -- In a three-day hearing that began Monday, a U.S. Food and Drug Administration advisory committee will give the maker of a drug meant to prevent premature births a chance to show why its drug should not be pulled off the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news